A Severity‐Agnostic Atrophy Pattern in Spinocerebellar Ataxia Type 3: Volumetrics from ENIGMA ‐Ataxia
Movement Disorders · 2026
DOI: 10.1002/mds.70349 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Movement Disorders, 2026. Verfasst von Jason W Robertson und 43 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Computer Science, Dalhousie University, Halifax, Nova Scotia, Canada. Hauptthemen laut MEDLINE: Machado-Joseph Disease, Brain. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Bundesministerium f r Bildung und Forschung, NINDS NIH HHS, National Ataxia Foundation Clinical Research Consortium.
Abstract (Originalsprache)
Background
Spinocerebellar ataxia type 3 (SCA3) is a rare, inherited neurodegenerative disease characterized by progressive loss of motor coordination.
Objectives
We undertook a multisite magnetic resonance imaging study to profile the spatial spread of atrophy across the brain, determine whether atrophy preferentially maps onto specific functional networks, and investigate the relationship between cerebellar and cerebral atrophy.
Methods
Whole‐brain grey and white matter (GM and WM) voxel‐based morphometry was performed on 408 individuals with SCA3 (82 pre‐ataxic) and 293 controls. The SCA3 cohort was stratified by ataxia severity to study progression. Cerebellar GM atrophy was mapped onto a task‐based functional atlas. Cerebrocerebellar volumetric covariance was assessed to determine whether cerebral and cerebellar atrophy were coupled.
Results
The atrophy pattern is spatially consistent but progressive in magnitude across the disease course. The greatest atrophy (Cohen's d > 1.5) occurred in the pons, cerebellar WM, and cerebellar peduncles; correlations with ataxia severity and duration were also strongest (−0.4 > r > −0.65) in those regions. Cerebellar GM atrophy was greatest ( d ≅ 0.7) in functional regions associated with motor planning/execution, attention, and emotional processing. Sparse cerebral cortical atrophy appears only in the most severe disease subgroup, while striatal atrophy begins in the earliest stages but does not worsen with increasing clinical severity. Reduced cerebrocerebellar volumetric covariance is observed in SCA3 participants versus controls.
Conclusions
Cerebellar and brainstem atrophy underlies greater ataxia severity in SCA3, but the spatial pattern of structural changes remains relatively consistent across the course of the disease. Cerebellar GM atrophy is spatially non‐uniform, and occurs maximally in regions consistent with the motor and cognitive clinical presentation of SCA3. Cerebellar atrophy is not mirrored by corresponding cerebral structural changes. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Computer Science, Dalhousie University, Halifax, Nova Scotia, Canada.
- Department of Radiology, Center for Magnetic Resonance Research, University of Minnesota Medical School, Minneapolis, Minnesota, USA.
- Department of Applied Physiology & Kinesiology, University of Florida, Gainesville, Florida, USA.
- Department of Neurology, Weill Cornell Medicine at Houston Methodist Research Institute, Houston, Texas, USA.
- Department of Diagnostic and Interventional Neuroradiology, University Hospital Tübingen, Tübingen, Germany.
- Department of Neurology, School of Medical Sciences, University of Campinas, Campinas, Brazil.
ORCID-Profile: Jason W Robertson, Isaac Adanyeguh, David J Arpin, Benjamin Bender, Fernando Cendes, Andreas Deistung, Alexandra Durr, Thomas Klockgether, Chen Liu, Alberto R M Martinez, Jerry L Prince, Kathrin Reetz, Thiago J R Rezende, David Vaillancourt, Carlos R Hernandez-Castillo
Förderung
- Bundesministerium f r Bildung und Forschung
- NINDS NIH HHS
- National Ataxia Foundation Clinical Research Consortium
- National Science Foundation
- Advanced Clinician Scientist Programme (ACCENT)
- Canada Research Chairs
- Australian National Health and Medical Research Council
- Natural Sciences and Engineering Research Council of Canada
Zitieren
APA
Robertson, J. W., Adanyeguh, I., Arpin, D. J., Ashizawa, T., Bender, B., Cendes, F., Chen, X., Coarelli, G., Coutinho, L., Deistung, A., Dogan, I., Durr, A., Faber, J., ESMI MR Study Group, Fernandez-Ruiz, J., Ferreira, M., França, M. C., Göricke, S. L., Han, S., …, & Hernandez-Castillo, C. R. (2026). A Severity‐Agnostic Atrophy Pattern in Spinocerebellar Ataxia Type 3: Volumetrics from ENIGMA ‐Ataxia. Movement Disorders. https://doi.org/10.1002/mds.70349
Vancouver
Robertson JW, Adanyeguh I, Arpin DJ, Ashizawa T, Bender B, Cendes F, et al. A Severity‐Agnostic Atrophy Pattern in Spinocerebellar Ataxia Type 3: Volumetrics from ENIGMA ‐Ataxia. Movement Disorders. 2026. doi:10.1002/mds.70349
BibTeX
@article{Robertson2026,
author = {Robertson, Jason W and Adanyeguh, Isaac and Arpin, David J and Ashizawa, Tetsuo and Bender, Benjamin and Cendes, Fernando and Chen, Xi and Coarelli, Giulia and Coutinho, Léo and Deistung, Andreas and Dogan, Imis and Durr, Alexandra and Faber, Jennifer and ESMI MR Study Group, ESMI MR Study Group and Fernandez-Ruiz, Juan and Ferreira, Mónica and França, Marcondes C and Göricke, Sophia L and Han, Shuo and Klockgether, Thomas and Liu, Chen and Luo, Jun and Martinez, Alberto R M and Ono, Sergio E and Onyike, Chiadi U and Öz, Gülin and EUROSCA MR Study Group, EUROSCA MR Study Group and Paulson, Henry and Prince, Jerry L and Reetz, Kathrin and Rezende, Thiago J R and Synofzik, Matthis and Ghizoni Teive, Hélio A and Thomopoulos, Sophia I and Thompson, Paul M and Timmann, Dagmar and Vaillancourt, David and van de Warrenburg, Bart and van Gaalen, Judith and Wang, Xingang and Wegner, Philipp and Ying, Sarah H and Harding, Ian H and Hernandez-Castillo, Carlos R},
title = {A Severity‐Agnostic Atrophy Pattern in Spinocerebellar Ataxia Type 3: Volumetrics from ENIGMA ‐Ataxia},
journal = {Movement Disorders},
year = {2026},
doi = {10.1002/mds.70349}
}
EUVIMED